Cerus Advisors has joined forces with Stork Capital Life Sciences to become their in-house life science team and lead Stork Capital’s life science investment program.

Kleanthis Xanthopoulos and the Cerus team are focused on supporting entrepreneurs and companies with transformative ideas to create meaningful life science, medical device, and healthcare service companies that can scale into successful and sustainable enterprises. With Cerus Advisors’ first-hand experience as entrepreneurs and founders of leading biotechnology and medical device companies, the Cerus team has navigated the scaling of early stage companies through multiple value-creating strategic partnerships, IPOs, and M&A exits.